ZBIO logo

Zenas BioPharma, Inc. (ZBIO) Cash From Financing

Annual CFF:

$412.96M+$392.84M(+1952.88%)
December 31, 2024

Summary

  • As of today, ZBIO annual cash from financing is $412.96 million, with the most recent change of +$392.84 million (+1952.88%) on December 31, 2024.
  • During the last 3 years, ZBIO annual cash from financing has risen by +$353.57 million (+595.32%).
  • ZBIO annual cash from financing is now at all-time high.

Performance

1-Year Change

+1952.88%

3-Year Change

+595.32%

5-Year Change

+595.32%

15-Year Change

+595.32%

ZBIO Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

95.62%
ZBIO annual cash from financing is higher than 95.62% of companies in Healthcare sector

Range

All-Time High

$412.96M
ZBIO annual cash from financing is currently at an all-time high

3-Year Low

$20.12M
ZBIO annual cash from financing is currently +1952.88% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ZBIO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Mar 17, 2026
ZBIO next annual earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

Annual CFI

-$30.55M
ZBIO annual cash from investing is -$30.55 million

Annual CFO

-$119.67M
ZBIO annual cash from operations is -$119.67 million

Annual FCF

-$119.81M
ZBIO annual free cash flow is -$119.81 million

Annual CAPEX

$131.00K
ZBIO annual capital expenditures is $131.00 thousand

Quarterly CFF:

$72.62M+$70.89M(+4116.96%)
September 30, 2025

Summary

  • As of today, ZBIO quarterly cash from financing is $72.62 million, with the most recent change of +$70.89 million (+4116.96%) on September 30, 2025.
  • Over the past year, ZBIO quarterly cash from financing has dropped by -$161.36 million (-68.96%).
  • ZBIO quarterly cash from financing is now -68.96% below its all-time high of $233.98 million, reached on September 30, 2024.

Performance

3-Month Change

+4116.96%

1-Year Change

-68.96%

3-Year Change

-

5-Year Change

-

ZBIO Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

93.32%
ZBIO quarterly cash from financing is higher than 93.32% of companies in Healthcare sector

Range

All-Time High

$233.98M
ZBIO quarterly cash from financing is currently -68.96% below its historical high of $233.98 million

3-Year Low

-$614.00K
ZBIO quarterly cash from financing is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ZBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 17, 2026
ZBIO next earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

Quarterly CFI

$40.04M
ZBIO quarterly cash from investing is $40.04 million

Quarterly CFO

-$41.13M
ZBIO quarterly cash from operations is -$41.13 million

Quarterly FCF

-$41.13M
ZBIO quarterly free cash flow is -$41.13 million

Quarterly CAPEX

$0.00
ZBIO quarterly capital expenditures is $0.00

TTM CFF:

$76.29M-$161.36M(-67.90%)
September 30, 2025

Summary

  • As of today, ZBIO TTM cash from financing is $76.29 million, with the most recent change of -$161.36 million (-67.90%) on September 30, 2025.
  • Over the past year, ZBIO TTM cash from financing has dropped by -$334.81 million (-81.44%).
  • ZBIO TTM cash from financing is now -81.56% below its all-time high of $413.67 million, reached on March 31, 2025.

Performance

3-Month Change

-67.9%

1-Year Change

-81.44%

3-Year Change

-

5-Year Change

-

ZBIO TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

83.47%
ZBIO TTM cash from financing is higher than 83.47% of companies in Healthcare sector

Range

All-Time High

$413.67M
ZBIO TTM cash from financing is currently -81.56% below its historical high of $413.67 million

3-Year Low

$55.00K
ZBIO TTM cash from financing is currently >+9900.00% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ZBIO previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Mar 17, 2026
ZBIO next earnings announcement is scheduled for Mar 17, 2026

OtherZBIOcash flow metrics

TTM CFI

-$162.26M
ZBIO TTM cash from investing is -$162.26 million

TTM CFO

-$158.47M
ZBIO TTM cash from operations is -$158.47 million

TTM FCF

-$158.56M
ZBIO TTM free cash flow is -$158.56 million

TTM CAPEX

$92.00K
ZBIO TTM capital expenditures is $92.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

ZBIO Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+1952.9%-69.0%-81.4%
3Y3 Years+595.3%--
5Y5 Years+595.3%--

ZBIO Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+1952.9%-69.0%>+9999.0%-81.6%>+9999.0%
5Y5-Yearat high+1952.9%-69.0%>+9999.0%-81.6%>+9999.0%
All-TimeAll-Timeat high+1952.9%-69.0%>+9999.0%-81.6%>+9999.0%

ZBIO Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2025
-
$72.62M(+4117.0%)
$76.29M(-67.9%)
Jun 2025
-
$1.72M(+1639.4%)
$237.65M(-42.5%)
Mar 2025
-
$99.00K(-94.7%)
$413.67M(+0.2%)
Dec 2024
$412.96M
$1.85M(-99.2%)
$412.96M(+0.5%)
Sep 2024
-
$233.98M(+31.6%)
$411.11M(+108.6%)
Jun 2024
-
$177.74M(>+9900.0%)
$197.13M(+916.3%)
DateAnnualQuarterlyTTM
Mar 2024
-
-$614.00K(-103.1%)
$19.40M(-3.3%)
Dec 2023
$20.12M(-66.1%)
-
-
Sep 2023
-
$20.00M(>+9900.0%)
$20.07M(>+9900.0%)
Jun 2023
-
$11.00K(-80.0%)
$66.00K(+20.0%)
Mar 2023
-
$55.00K
$55.00K
Dec 2022
$59.39M
-
-

FAQ

  • What is Zenas BioPharma, Inc. annual cash from financing?
  • What is the all-time high annual cash from financing for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. annual cash from financing year-on-year change?
  • What is Zenas BioPharma, Inc. quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. quarterly cash from financing year-on-year change?
  • What is Zenas BioPharma, Inc. TTM cash from financing?
  • What is the all-time high TTM cash from financing for Zenas BioPharma, Inc.?
  • What is Zenas BioPharma, Inc. TTM cash from financing year-on-year change?

What is Zenas BioPharma, Inc. annual cash from financing?

The current annual cash from financing of ZBIO is $412.96M

What is the all-time high annual cash from financing for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high annual cash from financing is $412.96M

What is Zenas BioPharma, Inc. annual cash from financing year-on-year change?

Over the past year, ZBIO annual cash from financing has changed by +$392.84M (+1952.88%)

What is Zenas BioPharma, Inc. quarterly cash from financing?

The current quarterly cash from financing of ZBIO is $72.62M

What is the all-time high quarterly cash from financing for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high quarterly cash from financing is $233.98M

What is Zenas BioPharma, Inc. quarterly cash from financing year-on-year change?

Over the past year, ZBIO quarterly cash from financing has changed by -$161.36M (-68.96%)

What is Zenas BioPharma, Inc. TTM cash from financing?

The current TTM cash from financing of ZBIO is $76.29M

What is the all-time high TTM cash from financing for Zenas BioPharma, Inc.?

Zenas BioPharma, Inc. all-time high TTM cash from financing is $413.67M

What is Zenas BioPharma, Inc. TTM cash from financing year-on-year change?

Over the past year, ZBIO TTM cash from financing has changed by -$334.81M (-81.44%)
On this page